Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Ghaffarpour, N; Baselga, E; Boon, LM; Diociaiuti, A; Dompmartin, A; Dvorakova, V; El, Hachem, M; Gasparella, P; Haxhija, E; Kyrklund, K; Irvine, AD; Kapp, FG; Rößler, J; Salminen, P; van, den, Bosch, C; van, der, Vleuten, C; Kool, LS; Vikkula, M.
The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformations.
Eur J Med Genet. 2022; 65(12):104637
Doi: 10.1016/j.ejmg.2022.104637
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Gasparella Paolo
- Haxhija Emir
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Lymphatic malformations (LMs) are developmental defects of lymphatic vessels. LMs are histologically benign lesions, however, due to localization, size, and unexpected swelling, they may cause serious complications that threaten vital functions such as compression of the airways. A large swelling of the face or neck may also be disfiguring and thus constitute a psychological strain for patients and their families. LMs are also highly immunologically reactive, and are prone to recurrent infections and inflammation causing pain as well as chronic oozing wounds. The European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN) is dedicated to gathering the best expertise in Europe. There are only few available guidelines on management and follow up of LMs, which commonly focus on very specific situations, such as head and neck LM (Zhou et al., 2011). It is still unclear, what constitutes an indication for treatment of LMs and how to follow up the patients. The Vascular Anomalies Working Group (VASCA-WG) of VASCERN decided to develop a diagnostic and management pathway for the management of LMs with a Nominal Group Technique (NGT), a well-established, structured, multistep, facilitated group meeting technique used to generate consensus statements. The pathway was drawn following 2 face-to-face meetings and multiple web meetings to facilitate discussion, and by mail to avoid the influence of most authoritative members. The VASCA-WG has produced this opinion statement reflecting strategies developed by experts and patient representatives on how to approach patients with lymphatic malformations in a practical manner; we present an algorithmic view of the results of our work.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Sclerotherapy - adverse effects, methods
- Treatment Outcome - administration & dosage
- Lymphatic Abnormalities - diagnosis, therapy, etiology
- Neck - administration & dosage
- Head - administration & dosage
- Retrospective Studies - administration & dosage
- Find related publications in this database (Keywords)
- Lymphatic malformation
- Vascular malformation
- Management
- Treatment algorithm
- PIK3CA
- Sirolimus
- Alpelisib
- Surgery
- Interventional radiology
- Sclerotherapy
- Patient pathway